Selected article for: "breath shortness cough and loss sore throat"

Author: Shoer, S.; Karady, T.; Keshet, A.; Shilo, S.; Rossman, H.; Gavrieli, A.; Meir, T.; Lavon, A.; Kolobkov, D.; Kalka, I.; Godneva, A.; Cohen, O.; Kariv, A.; Hoch, O.; Zer-Aviv, M.; Castel, N.; Ekka Zohar, A.; Irony, A.; Geiger, B.; Hizi, D.; Shalev, V.; Balicer, R.; Segal, E.
Title: Who should we test for COVID-19?A triage model built from national symptom surveys
  • Cord-id: ryibszjm
  • Document date: 2020_5_21
  • ID: ryibszjm
    Snippet: The gold standard for COVID-19 diagnosis is detection of viral RNA in a reverse transcription PCR test. Due to global limitations in testing capacity, effective prioritization of individuals for testing is essential. Here, we devised a model that estimates the probability of an individual to test positive for COVID-19 based on answers to 9 simple questions regarding age, gender, presence of prior medical conditions, general feeling, and the symptoms fever, cough, shortness of breath, sore throat
    Document: The gold standard for COVID-19 diagnosis is detection of viral RNA in a reverse transcription PCR test. Due to global limitations in testing capacity, effective prioritization of individuals for testing is essential. Here, we devised a model that estimates the probability of an individual to test positive for COVID-19 based on answers to 9 simple questions regarding age, gender, presence of prior medical conditions, general feeling, and the symptoms fever, cough, shortness of breath, sore throat and loss of taste or smell, all of which have been associated with COVID-19 infection. Our model was devised from a subsample of a national symptom survey that was answered over 2 million times in Israel over the past 2 months and a targeted survey distributed to all residents of several cities in Israel. Overall, 43,752 adults were included, from which 498 self-reported as being COVID-19 positive. The model provides statistically significant predictions on held-out individuals and achieves a positive predictive value (PPV) of 46.3% at a 10% sensitivity. As our tool can be used online and without the need of exposure to suspected patients, it may have worldwide utility in combating COVID-19 by better directing the limited testing resources through prioritization of individuals for testing, thereby increasing the rate at which positive individuals can be identified and isolated.

    Search related documents:
    Co phrase search for related documents
    • actively contact and machine learning model: 1
    • actual number and additional cost: 1
    • actual number and additional validation: 1
    • actual number and logistic regression: 1, 2
    • actual number and machine learning: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • actual number and machine learning model: 1, 2
    • additional cost and logistic regression: 1, 2, 3
    • additional cost and machine learning: 1, 2, 3
    • additional feature and logistic regression: 1
    • additional feature and machine learning: 1
    • additional symptom and logistic regression: 1
    • additional symptom and machine learning: 1
    • additional validation and logistic regression: 1, 2
    • additional validation and machine learning: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • additive explanation and logistic regression: 1, 2, 3
    • additive explanation and machine learning: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • additive explanation and machine learning model: 1, 2, 3
    • logistic regression and machine learning: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • logistic regression and machine learning model: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25